nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Methylprednisolone—multiple sclerosis	0.12	0.232	CbGbCtD
Scopolamine—ABCB1—Mitoxantrone—multiple sclerosis	0.0872	0.169	CbGbCtD
Scopolamine—ABCB1—Betamethasone—multiple sclerosis	0.0777	0.151	CbGbCtD
Scopolamine—ABCB1—Prednisolone—multiple sclerosis	0.0767	0.149	CbGbCtD
Scopolamine—ABCB1—Prednisone—multiple sclerosis	0.0724	0.141	CbGbCtD
Scopolamine—ABCB1—Dexamethasone—multiple sclerosis	0.0452	0.0878	CbGbCtD
Scopolamine—ABCB1—Methotrexate—multiple sclerosis	0.0363	0.0705	CbGbCtD
Scopolamine—Irritability—Methylprednisolone—multiple sclerosis	0.00158	0.00471	CcSEcCtD
Scopolamine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00155	0.00462	CcSEcCtD
Scopolamine—Hypotension—Cladribine—multiple sclerosis	0.00153	0.00458	CcSEcCtD
Scopolamine—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00151	0.00451	CcSEcCtD
Scopolamine—Psychotic disorder—Betamethasone—multiple sclerosis	0.00147	0.00439	CcSEcCtD
Scopolamine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00147	0.00439	CcSEcCtD
Scopolamine—Muscular weakness—Triamcinolone—multiple sclerosis	0.00146	0.00437	CcSEcCtD
Scopolamine—Somnolence—Cladribine—multiple sclerosis	0.00146	0.00436	CcSEcCtD
Scopolamine—Muscular weakness—Methylprednisolone—multiple sclerosis	0.00146	0.00436	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.00146	0.00435	CcSEcCtD
Scopolamine—Irritability—Betamethasone—multiple sclerosis	0.00143	0.00429	CcSEcCtD
Scopolamine—Irritability—Dexamethasone—multiple sclerosis	0.00143	0.00429	CcSEcCtD
Scopolamine—Fatigue—Cladribine—multiple sclerosis	0.00142	0.00423	CcSEcCtD
Scopolamine—Constipation—Cladribine—multiple sclerosis	0.0014	0.0042	CcSEcCtD
Scopolamine—Pain—Cladribine—multiple sclerosis	0.0014	0.0042	CcSEcCtD
Scopolamine—Amnesia—Prednisone—multiple sclerosis	0.00139	0.00416	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00138	0.00413	CcSEcCtD
Scopolamine—Dry skin—Dexamethasone—multiple sclerosis	0.00138	0.00412	CcSEcCtD
Scopolamine—Dry skin—Betamethasone—multiple sclerosis	0.00138	0.00412	CcSEcCtD
Scopolamine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00136	0.00405	CcSEcCtD
Scopolamine—Feeling abnormal—Cladribine—multiple sclerosis	0.00135	0.00404	CcSEcCtD
Scopolamine—Conjunctivitis—Prednisolone—multiple sclerosis	0.00135	0.00403	CcSEcCtD
Scopolamine—Muscular weakness—Dexamethasone—multiple sclerosis	0.00133	0.00396	CcSEcCtD
Scopolamine—Muscular weakness—Betamethasone—multiple sclerosis	0.00133	0.00396	CcSEcCtD
Scopolamine—Erythema—Mitoxantrone—multiple sclerosis	0.00132	0.00395	CcSEcCtD
Scopolamine—SI—nervous system—multiple sclerosis	0.0013	0.127	CbGeAlD
Scopolamine—Abdominal pain—Cladribine—multiple sclerosis	0.0013	0.00388	CcSEcCtD
Scopolamine—Body temperature increased—Cladribine—multiple sclerosis	0.0013	0.00388	CcSEcCtD
Scopolamine—Skin disorder—Azathioprine—multiple sclerosis	0.0013	0.00387	CcSEcCtD
Scopolamine—Psychotic disorder—Prednisone—multiple sclerosis	0.00128	0.00382	CcSEcCtD
Scopolamine—Bradycardia—Prednisolone—multiple sclerosis	0.00127	0.00379	CcSEcCtD
Scopolamine—SI—central nervous system—multiple sclerosis	0.00125	0.122	CbGeAlD
Scopolamine—Irritability—Prednisone—multiple sclerosis	0.00125	0.00373	CcSEcCtD
Scopolamine—Hypotension—Azathioprine—multiple sclerosis	0.00125	0.00373	CcSEcCtD
Scopolamine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00125	0.00372	CcSEcCtD
Scopolamine—Conjunctivitis—Triamcinolone—multiple sclerosis	0.00124	0.00371	CcSEcCtD
Scopolamine—Sweating—Methylprednisolone—multiple sclerosis	0.00122	0.00365	CcSEcCtD
Scopolamine—Visual impairment—Prednisolone—multiple sclerosis	0.0012	0.00359	CcSEcCtD
Scopolamine—Dry skin—Prednisone—multiple sclerosis	0.0012	0.00359	CcSEcCtD
Scopolamine—Asthenia—Cladribine—multiple sclerosis	0.00118	0.00352	CcSEcCtD
Scopolamine—Bradycardia—Triamcinolone—multiple sclerosis	0.00117	0.00349	CcSEcCtD
Scopolamine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00116	0.00348	CcSEcCtD
Scopolamine—Pruritus—Cladribine—multiple sclerosis	0.00116	0.00347	CcSEcCtD
Scopolamine—Muscular weakness—Prednisone—multiple sclerosis	0.00115	0.00345	CcSEcCtD
Scopolamine—Hallucination—Methylprednisolone—multiple sclerosis	0.00114	0.0034	CcSEcCtD
Scopolamine—Pharyngitis—Triamcinolone—multiple sclerosis	0.00114	0.0034	CcSEcCtD
Scopolamine—Conjunctivitis—Dexamethasone—multiple sclerosis	0.00113	0.00336	CcSEcCtD
Scopolamine—Conjunctivitis—Betamethasone—multiple sclerosis	0.00113	0.00336	CcSEcCtD
Scopolamine—Arrhythmia—Prednisolone—multiple sclerosis	0.00111	0.00333	CcSEcCtD
Scopolamine—Visual impairment—Methylprednisolone—multiple sclerosis	0.0011	0.00329	CcSEcCtD
Scopolamine—Feeling abnormal—Azathioprine—multiple sclerosis	0.0011	0.00329	CcSEcCtD
Scopolamine—Confusional state—Mitoxantrone—multiple sclerosis	0.00109	0.00325	CcSEcCtD
Scopolamine—Dizziness—Cladribine—multiple sclerosis	0.00109	0.00324	CcSEcCtD
Scopolamine—Erythema—Prednisolone—multiple sclerosis	0.00109	0.00324	CcSEcCtD
Scopolamine—Oedema—Mitoxantrone—multiple sclerosis	0.00108	0.00322	CcSEcCtD
Scopolamine—Eye disorder—Methylprednisolone—multiple sclerosis	0.00107	0.00319	CcSEcCtD
Scopolamine—Bradycardia—Betamethasone—multiple sclerosis	0.00106	0.00316	CcSEcCtD
Scopolamine—Bradycardia—Dexamethasone—multiple sclerosis	0.00106	0.00316	CcSEcCtD
Scopolamine—Body temperature increased—Azathioprine—multiple sclerosis	0.00106	0.00315	CcSEcCtD
Scopolamine—Abdominal pain—Azathioprine—multiple sclerosis	0.00106	0.00315	CcSEcCtD
Scopolamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00105	0.00315	CcSEcCtD
Scopolamine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00105	0.00313	CcSEcCtD
Scopolamine—Irritability—Methotrexate—multiple sclerosis	0.00104	0.00312	CcSEcCtD
Scopolamine—Vomiting—Cladribine—multiple sclerosis	0.00104	0.00312	CcSEcCtD
Scopolamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00104	0.00312	CcSEcCtD
Scopolamine—Rash—Cladribine—multiple sclerosis	0.00104	0.00309	CcSEcCtD
Scopolamine—Hallucination—Dexamethasone—multiple sclerosis	0.00103	0.00309	CcSEcCtD
Scopolamine—Hallucination—Betamethasone—multiple sclerosis	0.00103	0.00309	CcSEcCtD
Scopolamine—Dermatitis—Cladribine—multiple sclerosis	0.00103	0.00309	CcSEcCtD
Scopolamine—Headache—Cladribine—multiple sclerosis	0.00103	0.00307	CcSEcCtD
Scopolamine—Arrhythmia—Triamcinolone—multiple sclerosis	0.00102	0.00306	CcSEcCtD
Scopolamine—Vision blurred—Prednisolone—multiple sclerosis	0.00102	0.00306	CcSEcCtD
Scopolamine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00102	0.00305	CcSEcCtD
Scopolamine—Hypotension—Mitoxantrone—multiple sclerosis	0.00101	0.00301	CcSEcCtD
Scopolamine—Visual impairment—Dexamethasone—multiple sclerosis	0.001	0.00299	CcSEcCtD
Scopolamine—Visual impairment—Betamethasone—multiple sclerosis	0.001	0.00299	CcSEcCtD
Scopolamine—Mental disorder—Methylprednisolone—multiple sclerosis	0.001	0.00299	CcSEcCtD
Scopolamine—Erythema—Triamcinolone—multiple sclerosis	0.000998	0.00298	CcSEcCtD
Scopolamine—Erythema—Methylprednisolone—multiple sclerosis	0.000996	0.00297	CcSEcCtD
Scopolamine—SI—brain—multiple sclerosis	0.000993	0.0971	CbGeAlD
Scopolamine—Nausea—Cladribine—multiple sclerosis	0.000975	0.00291	CcSEcCtD
Scopolamine—Vertigo—Prednisolone—multiple sclerosis	0.000975	0.00291	CcSEcCtD
Scopolamine—Eye disorder—Dexamethasone—multiple sclerosis	0.000972	0.0029	CcSEcCtD
Scopolamine—Eye disorder—Betamethasone—multiple sclerosis	0.000972	0.0029	CcSEcCtD
Scopolamine—Somnolence—Mitoxantrone—multiple sclerosis	0.00096	0.00287	CcSEcCtD
Scopolamine—Fatigue—Mitoxantrone—multiple sclerosis	0.000931	0.00278	CcSEcCtD
Scopolamine—Arrhythmia—Betamethasone—multiple sclerosis	0.000929	0.00278	CcSEcCtD
Scopolamine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000929	0.00278	CcSEcCtD
Scopolamine—Constipation—Mitoxantrone—multiple sclerosis	0.000923	0.00276	CcSEcCtD
Scopolamine—Pain—Mitoxantrone—multiple sclerosis	0.000923	0.00276	CcSEcCtD
Scopolamine—Bradycardia—Prednisone—multiple sclerosis	0.000922	0.00275	CcSEcCtD
Scopolamine—Erythema—Dexamethasone—multiple sclerosis	0.000905	0.0027	CcSEcCtD
Scopolamine—Erythema—Betamethasone—multiple sclerosis	0.000905	0.0027	CcSEcCtD
Scopolamine—Hallucination—Prednisone—multiple sclerosis	0.000901	0.00269	CcSEcCtD
Scopolamine—Vertigo—Triamcinolone—multiple sclerosis	0.000896	0.00268	CcSEcCtD
Scopolamine—Vertigo—Methylprednisolone—multiple sclerosis	0.000895	0.00267	CcSEcCtD
Scopolamine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000889	0.00266	CcSEcCtD
Scopolamine—Oedema—Prednisolone—multiple sclerosis	0.000886	0.00265	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—multiple sclerosis	0.000884	0.00264	CcSEcCtD
Scopolamine—Dizziness—Azathioprine—multiple sclerosis	0.000883	0.00264	CcSEcCtD
Scopolamine—Tachycardia—Prednisolone—multiple sclerosis	0.000864	0.00258	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000856	0.00256	CcSEcCtD
Scopolamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000853	0.00255	CcSEcCtD
Scopolamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000853	0.00255	CcSEcCtD
Scopolamine—Vomiting—Azathioprine—multiple sclerosis	0.000849	0.00254	CcSEcCtD
Scopolamine—Eye disorder—Prednisone—multiple sclerosis	0.000846	0.00253	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—multiple sclerosis	0.000843	0.00252	CcSEcCtD
Scopolamine—Rash—Azathioprine—multiple sclerosis	0.000842	0.00252	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000842	0.00251	CcSEcCtD
Scopolamine—Dermatitis—Azathioprine—multiple sclerosis	0.000841	0.00251	CcSEcCtD
Scopolamine—Flushing—Prednisone—multiple sclerosis	0.000841	0.00251	CcSEcCtD
Scopolamine—Headache—Azathioprine—multiple sclerosis	0.000836	0.0025	CcSEcCtD
Scopolamine—Dry mouth—Triamcinolone—multiple sclerosis	0.000831	0.00248	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—multiple sclerosis	0.00082	0.00245	CcSEcCtD
Scopolamine—Confusional state—Methylprednisolone—multiple sclerosis	0.000819	0.00245	CcSEcCtD
Scopolamine—Oedema—Triamcinolone—multiple sclerosis	0.000814	0.00243	CcSEcCtD
Scopolamine—Vertigo—Dexamethasone—multiple sclerosis	0.000813	0.00243	CcSEcCtD
Scopolamine—Vertigo—Betamethasone—multiple sclerosis	0.000813	0.00243	CcSEcCtD
Scopolamine—Arrhythmia—Prednisone—multiple sclerosis	0.000809	0.00242	CcSEcCtD
Scopolamine—Sweating—Methotrexate—multiple sclerosis	0.000808	0.00242	CcSEcCtD
Scopolamine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000797	0.00238	CcSEcCtD
Scopolamine—Tachycardia—Triamcinolone—multiple sclerosis	0.000795	0.00237	CcSEcCtD
Scopolamine—Mental disorder—Prednisone—multiple sclerosis	0.000794	0.00237	CcSEcCtD
Scopolamine—Nausea—Azathioprine—multiple sclerosis	0.000793	0.00237	CcSEcCtD
Scopolamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000793	0.00237	CcSEcCtD
Scopolamine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000789	0.00236	CcSEcCtD
Scopolamine—Erythema—Prednisone—multiple sclerosis	0.000788	0.00236	CcSEcCtD
Scopolamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000787	0.00235	CcSEcCtD
Scopolamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000786	0.00235	CcSEcCtD
Scopolamine—Asthenia—Mitoxantrone—multiple sclerosis	0.000774	0.00231	CcSEcCtD
Scopolamine—Hypotension—Methylprednisolone—multiple sclerosis	0.000759	0.00227	CcSEcCtD
Scopolamine—Pain—Prednisolone—multiple sclerosis	0.000757	0.00226	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—multiple sclerosis	0.000751	0.00224	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000748	0.00223	CcSEcCtD
Scopolamine—Vision blurred—Prednisone—multiple sclerosis	0.000743	0.00222	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—multiple sclerosis	0.000742	0.00222	CcSEcCtD
Scopolamine—Oedema—Betamethasone—multiple sclerosis	0.000739	0.00221	CcSEcCtD
Scopolamine—Oedema—Dexamethasone—multiple sclerosis	0.000739	0.00221	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00073	0.00218	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—multiple sclerosis	0.000729	0.00218	CcSEcCtD
Scopolamine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000725	0.00216	CcSEcCtD
Scopolamine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000725	0.00216	CcSEcCtD
Scopolamine—Agitation—Prednisone—multiple sclerosis	0.000725	0.00216	CcSEcCtD
Scopolamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000721	0.00215	CcSEcCtD
Scopolamine—Tachycardia—Betamethasone—multiple sclerosis	0.000721	0.00215	CcSEcCtD
Scopolamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000714	0.00213	CcSEcCtD
Scopolamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000714	0.00213	CcSEcCtD
Scopolamine—Vertigo—Prednisone—multiple sclerosis	0.000708	0.00212	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—multiple sclerosis	0.000707	0.00211	CcSEcCtD
Scopolamine—Fatigue—Triamcinolone—multiple sclerosis	0.000702	0.0021	CcSEcCtD
Scopolamine—Fatigue—Methylprednisolone—multiple sclerosis	0.000701	0.00209	CcSEcCtD
Scopolamine—Pain—Triamcinolone—multiple sclerosis	0.000696	0.00208	CcSEcCtD
Scopolamine—Hypotension—Betamethasone—multiple sclerosis	0.00069	0.00206	CcSEcCtD
Scopolamine—Hypotension—Dexamethasone—multiple sclerosis	0.00069	0.00206	CcSEcCtD
Scopolamine—Vomiting—Mitoxantrone—multiple sclerosis	0.000686	0.00205	CcSEcCtD
Scopolamine—Rash—Mitoxantrone—multiple sclerosis	0.000681	0.00203	CcSEcCtD
Scopolamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00068	0.00203	CcSEcCtD
Scopolamine—Headache—Mitoxantrone—multiple sclerosis	0.000676	0.00202	CcSEcCtD
Scopolamine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000671	0.002	CcSEcCtD
Scopolamine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00067	0.002	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000667	0.00199	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—multiple sclerosis	0.000663	0.00198	CcSEcCtD
Scopolamine—Erythema—Methotrexate—multiple sclerosis	0.000659	0.00197	CcSEcCtD
Scopolamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000644	0.00192	CcSEcCtD
Scopolamine—Oedema—Prednisone—multiple sclerosis	0.000644	0.00192	CcSEcCtD
Scopolamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000642	0.00192	CcSEcCtD
Scopolamine—CHRM4—nervous system—multiple sclerosis	0.000642	0.0627	CbGeAlD
Scopolamine—Nausea—Mitoxantrone—multiple sclerosis	0.000641	0.00192	CcSEcCtD
Scopolamine—Fatigue—Dexamethasone—multiple sclerosis	0.000637	0.0019	CcSEcCtD
Scopolamine—Fatigue—Betamethasone—multiple sclerosis	0.000637	0.0019	CcSEcCtD
Scopolamine—Pain—Betamethasone—multiple sclerosis	0.000632	0.00189	CcSEcCtD
Scopolamine—Pain—Dexamethasone—multiple sclerosis	0.000632	0.00189	CcSEcCtD
Scopolamine—Nervous system disorder—Prednisone—multiple sclerosis	0.000631	0.00189	CcSEcCtD
Scopolamine—Tachycardia—Prednisone—multiple sclerosis	0.000628	0.00188	CcSEcCtD
Scopolamine—Skin disorder—Prednisone—multiple sclerosis	0.000625	0.00187	CcSEcCtD
Scopolamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000622	0.00186	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—multiple sclerosis	0.000621	0.00186	CcSEcCtD
Scopolamine—CHRM4—central nervous system—multiple sclerosis	0.000618	0.0604	CbGeAlD
Scopolamine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000609	0.00182	CcSEcCtD
Scopolamine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000609	0.00182	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—multiple sclerosis	0.000592	0.00177	CcSEcCtD
Scopolamine—Dizziness—Prednisolone—multiple sclerosis	0.000586	0.00175	CcSEcCtD
Scopolamine—Asthenia—Triamcinolone—multiple sclerosis	0.000584	0.00175	CcSEcCtD
Scopolamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000584	0.00175	CcSEcCtD
Scopolamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000584	0.00175	CcSEcCtD
Scopolamine—Abdominal pain—Betamethasone—multiple sclerosis	0.000584	0.00175	CcSEcCtD
Scopolamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000584	0.00175	CcSEcCtD
Scopolamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000583	0.00174	CcSEcCtD
Scopolamine—Pruritus—Triamcinolone—multiple sclerosis	0.000576	0.00172	CcSEcCtD
Scopolamine—Pruritus—Methylprednisolone—multiple sclerosis	0.000575	0.00172	CcSEcCtD
Scopolamine—Rash—Prednisolone—multiple sclerosis	0.000558	0.00167	CcSEcCtD
Scopolamine—Dermatitis—Prednisolone—multiple sclerosis	0.000558	0.00167	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000557	0.00166	CcSEcCtD
Scopolamine—Fatigue—Prednisone—multiple sclerosis	0.000555	0.00166	CcSEcCtD
Scopolamine—Headache—Prednisolone—multiple sclerosis	0.000555	0.00166	CcSEcCtD
Scopolamine—Constipation—Prednisone—multiple sclerosis	0.00055	0.00164	CcSEcCtD
Scopolamine—Confusional state—Methotrexate—multiple sclerosis	0.000542	0.00162	CcSEcCtD
Scopolamine—Dizziness—Triamcinolone—multiple sclerosis	0.000539	0.00161	CcSEcCtD
Scopolamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000537	0.00161	CcSEcCtD
Scopolamine—Feeling abnormal—Prednisone—multiple sclerosis	0.00053	0.00158	CcSEcCtD
Scopolamine—Asthenia—Dexamethasone—multiple sclerosis	0.00053	0.00158	CcSEcCtD
Scopolamine—Asthenia—Betamethasone—multiple sclerosis	0.00053	0.00158	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000527	0.00158	CcSEcCtD
Scopolamine—Nausea—Prednisolone—multiple sclerosis	0.000526	0.00157	CcSEcCtD
Scopolamine—Pruritus—Betamethasone—multiple sclerosis	0.000523	0.00156	CcSEcCtD
Scopolamine—Pruritus—Dexamethasone—multiple sclerosis	0.000523	0.00156	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—multiple sclerosis	0.000522	0.00156	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00052	0.00155	CcSEcCtD
Scopolamine—Vomiting—Triamcinolone—multiple sclerosis	0.000518	0.00155	CcSEcCtD
Scopolamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000517	0.00154	CcSEcCtD
Scopolamine—Rash—Triamcinolone—multiple sclerosis	0.000513	0.00153	CcSEcCtD
Scopolamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000513	0.00153	CcSEcCtD
Scopolamine—Rash—Methylprednisolone—multiple sclerosis	0.000512	0.00153	CcSEcCtD
Scopolamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000512	0.00153	CcSEcCtD
Scopolamine—Headache—Triamcinolone—multiple sclerosis	0.00051	0.00152	CcSEcCtD
Scopolamine—Headache—Methylprednisolone—multiple sclerosis	0.000509	0.00152	CcSEcCtD
Scopolamine—Body temperature increased—Prednisone—multiple sclerosis	0.000509	0.00152	CcSEcCtD
Scopolamine—Abdominal pain—Prednisone—multiple sclerosis	0.000509	0.00152	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—multiple sclerosis	0.000503	0.0015	CcSEcCtD
Scopolamine—CHRM5—nervous system—multiple sclerosis	0.000502	0.049	CbGeAlD
Scopolamine—CHRM4—brain—multiple sclerosis	0.00049	0.0479	CbGeAlD
Scopolamine—Dizziness—Betamethasone—multiple sclerosis	0.000489	0.00146	CcSEcCtD
Scopolamine—Dizziness—Dexamethasone—multiple sclerosis	0.000489	0.00146	CcSEcCtD
Scopolamine—Nausea—Triamcinolone—multiple sclerosis	0.000484	0.00145	CcSEcCtD
Scopolamine—CHRM5—central nervous system—multiple sclerosis	0.000483	0.0472	CbGeAlD
Scopolamine—Nausea—Methylprednisolone—multiple sclerosis	0.000483	0.00144	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—multiple sclerosis	0.000478	0.00143	CcSEcCtD
Scopolamine—Vomiting—Dexamethasone—multiple sclerosis	0.00047	0.0014	CcSEcCtD
Scopolamine—Vomiting—Betamethasone—multiple sclerosis	0.00047	0.0014	CcSEcCtD
Scopolamine—Rash—Dexamethasone—multiple sclerosis	0.000466	0.00139	CcSEcCtD
Scopolamine—Rash—Betamethasone—multiple sclerosis	0.000466	0.00139	CcSEcCtD
Scopolamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000465	0.00139	CcSEcCtD
Scopolamine—Dermatitis—Betamethasone—multiple sclerosis	0.000465	0.00139	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—multiple sclerosis	0.000464	0.00139	CcSEcCtD
Scopolamine—Headache—Dexamethasone—multiple sclerosis	0.000463	0.00138	CcSEcCtD
Scopolamine—Headache—Betamethasone—multiple sclerosis	0.000463	0.00138	CcSEcCtD
Scopolamine—Asthenia—Prednisone—multiple sclerosis	0.000462	0.00138	CcSEcCtD
Scopolamine—Pain—Methotrexate—multiple sclerosis	0.00046	0.00137	CcSEcCtD
Scopolamine—Pruritus—Prednisone—multiple sclerosis	0.000455	0.00136	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000443	0.00132	CcSEcCtD
Scopolamine—Nausea—Dexamethasone—multiple sclerosis	0.000439	0.00131	CcSEcCtD
Scopolamine—Nausea—Betamethasone—multiple sclerosis	0.000439	0.00131	CcSEcCtD
Scopolamine—Dizziness—Prednisone—multiple sclerosis	0.000426	0.00127	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000425	0.00127	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—multiple sclerosis	0.000425	0.00127	CcSEcCtD
Scopolamine—Vomiting—Prednisone—multiple sclerosis	0.000409	0.00122	CcSEcCtD
Scopolamine—Rash—Prednisone—multiple sclerosis	0.000406	0.00121	CcSEcCtD
Scopolamine—Dermatitis—Prednisone—multiple sclerosis	0.000405	0.00121	CcSEcCtD
Scopolamine—Headache—Prednisone—multiple sclerosis	0.000403	0.0012	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—multiple sclerosis	0.000386	0.00115	CcSEcCtD
Scopolamine—CHRM5—brain—multiple sclerosis	0.000383	0.0375	CbGeAlD
Scopolamine—Nausea—Prednisone—multiple sclerosis	0.000382	0.00114	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—multiple sclerosis	0.00038	0.00114	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—multiple sclerosis	0.000356	0.00106	CcSEcCtD
Scopolamine—CHRM2—nervous system—multiple sclerosis	0.000344	0.0337	CbGeAlD
Scopolamine—Vomiting—Methotrexate—multiple sclerosis	0.000342	0.00102	CcSEcCtD
Scopolamine—Rash—Methotrexate—multiple sclerosis	0.000339	0.00101	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—multiple sclerosis	0.000339	0.00101	CcSEcCtD
Scopolamine—Headache—Methotrexate—multiple sclerosis	0.000337	0.00101	CcSEcCtD
Scopolamine—CHRM2—central nervous system—multiple sclerosis	0.000331	0.0324	CbGeAlD
Scopolamine—Nausea—Methotrexate—multiple sclerosis	0.000319	0.000954	CcSEcCtD
Scopolamine—CHRM1—nervous system—multiple sclerosis	0.000313	0.0306	CbGeAlD
Scopolamine—CHRM1—central nervous system—multiple sclerosis	0.000302	0.0295	CbGeAlD
Scopolamine—CHRM3—nervous system—multiple sclerosis	0.00028	0.0274	CbGeAlD
Scopolamine—CHRM3—central nervous system—multiple sclerosis	0.00027	0.0264	CbGeAlD
Scopolamine—CHRM2—brain—multiple sclerosis	0.000263	0.0257	CbGeAlD
Scopolamine—CHRM1—brain—multiple sclerosis	0.00024	0.0234	CbGeAlD
Scopolamine—CHRM3—brain—multiple sclerosis	0.000214	0.021	CbGeAlD
Scopolamine—ABCB1—retina—multiple sclerosis	0.000201	0.0196	CbGeAlD
Scopolamine—ABCB1—medulla oblongata—multiple sclerosis	0.000145	0.0142	CbGeAlD
Scopolamine—ABCB1—midbrain—multiple sclerosis	0.000133	0.013	CbGeAlD
Scopolamine—ABCB1—spinal cord—multiple sclerosis	0.000129	0.0127	CbGeAlD
Scopolamine—ABCB1—nervous system—multiple sclerosis	0.000109	0.0107	CbGeAlD
Scopolamine—ABCB1—central nervous system—multiple sclerosis	0.000105	0.0103	CbGeAlD
Scopolamine—ABCB1—cerebellum—multiple sclerosis	0.000103	0.01	CbGeAlD
Scopolamine—CHRM4—GPCR downstream signaling—CCR5—multiple sclerosis	9.39e-05	0.00067	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	9.38e-05	0.000669	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	9.32e-05	0.000665	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL2RA—multiple sclerosis	9.26e-05	0.000661	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	9.18e-05	0.000655	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	9.15e-05	0.000653	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	9.07e-05	0.000647	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	9.07e-05	0.000647	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	9.06e-05	0.000646	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	9.04e-05	0.000645	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	9e-05	0.000642	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	8.95e-05	0.000639	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	8.95e-05	0.000638	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	8.93e-05	0.000637	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	8.93e-05	0.000637	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	8.93e-05	0.000637	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	8.92e-05	0.000636	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	8.9e-05	0.000635	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	8.87e-05	0.000633	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	8.83e-05	0.00063	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	8.81e-05	0.000629	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.79e-05	0.000627	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	8.76e-05	0.000625	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.76e-05	0.000625	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	8.73e-05	0.000623	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	8.65e-05	0.000617	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	8.65e-05	0.000617	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.61e-05	0.000615	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	8.57e-05	0.000612	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	8.54e-05	0.00061	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	8.53e-05	0.000609	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	8.46e-05	0.000604	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	8.41e-05	0.0006	CbGpPWpGaD
Scopolamine—ABCB1—brain—multiple sclerosis	8.34e-05	0.00815	CbGeAlD
Scopolamine—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	8.32e-05	0.000594	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	8.28e-05	0.000591	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	8.24e-05	0.000588	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	8.21e-05	0.000586	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PGR—multiple sclerosis	8.2e-05	0.000585	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	8.18e-05	0.000584	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	8.18e-05	0.000584	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	8.17e-05	0.000583	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	8.17e-05	0.000583	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPC5—multiple sclerosis	8.17e-05	0.000583	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	8.16e-05	0.000582	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	8.16e-05	0.000582	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	8.14e-05	0.000581	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	8.13e-05	0.00058	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	8.08e-05	0.000576	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	8.08e-05	0.000576	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	8.06e-05	0.000575	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	8.05e-05	0.000574	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	8.04e-05	0.000574	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	7.97e-05	0.000569	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CD28—multiple sclerosis	7.96e-05	0.000568	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PGR—multiple sclerosis	7.85e-05	0.00056	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	7.82e-05	0.000558	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	7.7e-05	0.000549	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CD28—multiple sclerosis	7.63e-05	0.000544	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	7.49e-05	0.000534	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	7.42e-05	0.000529	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	7.39e-05	0.000528	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	7.34e-05	0.000524	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	7.32e-05	0.000522	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	7.22e-05	0.000515	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	7.12e-05	0.000508	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	7.03e-05	0.000502	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	7.03e-05	0.000502	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	7.01e-05	0.0005	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	6.94e-05	0.000495	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	6.91e-05	0.000493	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RRM1—multiple sclerosis	6.77e-05	0.000483	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.75e-05	0.000482	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.73e-05	0.00048	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	6.67e-05	0.000476	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	6.52e-05	0.000465	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	6.5e-05	0.000464	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	6.38e-05	0.000456	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	6.38e-05	0.000456	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	6.36e-05	0.000454	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	6.33e-05	0.000452	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	6.31e-05	0.000451	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	6.3e-05	0.00045	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	6.25e-05	0.000446	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	6.25e-05	0.000446	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.24e-05	0.000446	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	6.24e-05	0.000445	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.23e-05	0.000444	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	6.22e-05	0.000444	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	6.22e-05	0.000444	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	6.16e-05	0.00044	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—BCHE—multiple sclerosis	6.13e-05	0.000437	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.11e-05	0.000436	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	5.92e-05	0.000423	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	5.83e-05	0.000416	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.82e-05	0.000415	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	5.81e-05	0.000415	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	5.76e-05	0.000411	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	5.75e-05	0.00041	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	5.73e-05	0.000409	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CD86—multiple sclerosis	5.68e-05	0.000405	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	5.68e-05	0.000405	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	5.67e-05	0.000405	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	5.67e-05	0.000404	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	5.65e-05	0.000403	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	5.61e-05	0.0004	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	5.59e-05	0.000399	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	5.59e-05	0.000399	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	5.54e-05	0.000395	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	5.53e-05	0.000394	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	5.51e-05	0.000393	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	5.46e-05	0.000389	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CD86—multiple sclerosis	5.44e-05	0.000388	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	5.43e-05	0.000387	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	5.42e-05	0.000387	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	5.4e-05	0.000386	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	5.37e-05	0.000383	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	5.36e-05	0.000382	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	5.35e-05	0.000382	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	5.35e-05	0.000382	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	5.3e-05	0.000378	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	5.27e-05	0.000376	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	5.26e-05	0.000375	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	5.21e-05	0.000371	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	5.2e-05	0.000371	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	5.18e-05	0.00037	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	5.04e-05	0.00036	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	4.97e-05	0.000354	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	4.96e-05	0.000354	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	4.95e-05	0.000353	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	4.93e-05	0.000352	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	4.93e-05	0.000352	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	4.89e-05	0.000349	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	4.87e-05	0.000347	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	4.85e-05	0.000346	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	4.83e-05	0.000344	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	4.8e-05	0.000343	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	4.76e-05	0.000339	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	4.72e-05	0.000337	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—multiple sclerosis	4.58e-05	0.000327	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	4.5e-05	0.000321	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	4.48e-05	0.00032	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	4.44e-05	0.000317	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	4.4e-05	0.000314	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—multiple sclerosis	4.39e-05	0.000313	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	4.38e-05	0.000313	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	4.38e-05	0.000313	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	4.37e-05	0.000312	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	4.34e-05	0.00031	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	4.32e-05	0.000309	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CD80—multiple sclerosis	4.14e-05	0.000296	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	3.99e-05	0.000285	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	3.98e-05	0.000284	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CD80—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	3.94e-05	0.000281	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—POMC—multiple sclerosis	3.94e-05	0.000281	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.91e-05	0.000279	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BCHE—multiple sclerosis	3.89e-05	0.000277	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	3.85e-05	0.000275	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	3.83e-05	0.000273	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	3.82e-05	0.000272	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	3.78e-05	0.00027	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—multiple sclerosis	3.77e-05	0.000269	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	3.77e-05	0.000269	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	3.77e-05	0.000269	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	3.76e-05	0.000268	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	3.72e-05	0.000266	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	3.69e-05	0.000263	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—multiple sclerosis	3.69e-05	0.000263	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	3.66e-05	0.000261	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	3.65e-05	0.00026	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	3.61e-05	0.000258	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	3.61e-05	0.000258	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	3.5e-05	0.00025	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	3.49e-05	0.000249	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	3.48e-05	0.000248	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	3.45e-05	0.000246	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	3.4e-05	0.000242	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	3.39e-05	0.000242	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	3.35e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	3.35e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.35e-05	0.000239	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	3.34e-05	0.000238	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	3.32e-05	0.000237	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	3.31e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	3.31e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	3.28e-05	0.000234	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—multiple sclerosis	3.17e-05	0.000226	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	3.09e-05	0.000221	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	3.08e-05	0.00022	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	3.05e-05	0.000218	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	2.91e-05	0.000208	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	2.9e-05	0.000207	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—multiple sclerosis	2.89e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	2.79e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	2.79e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	2.79e-05	0.000199	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	2.77e-05	0.000198	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	2.76e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	2.76e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	2.66e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	2.65e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	2.64e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	2.62e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	2.6e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	2.59e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	2.56e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	2.54e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	2.53e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	2.51e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	2.45e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	2.36e-05	0.000168	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	2.35e-05	0.000168	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	2.35e-05	0.000167	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—multiple sclerosis	2.34e-05	0.000167	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	2.33e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	2.28e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	2.27e-05	0.000162	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	2.23e-05	0.000159	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	2.18e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	2.17e-05	0.000155	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	2.13e-05	0.000152	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—multiple sclerosis	2.01e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	1.96e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	1.96e-05	0.00014	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	1.95e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	1.95e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	1.94e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	1.93e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	1.86e-05	0.000133	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	1.85e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	1.83e-05	0.000131	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—multiple sclerosis	1.83e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	1.71e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.65e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.65e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	1.64e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.63e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.54e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.53e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	1.53e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	1.53e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.52e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.51e-05	0.000108	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	1.5e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.48e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	8.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	8.21e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	1.14e-05	8.13e-05	CbGpPWpGaD
